Management of infections caused by Extended-spectrum beta-lactamase-producing Enterobacterales in Indian patients

This guidance document highlights the importance of early and accurate identification of ESBL -producing Enterobacterales, outlines clinical syndromes that may require empirical antibiotic coverage for ESBLs, and offers guidance on appropriate de-escalation strategies. Additionally, it emphasizes on the optimal use of use of newer beta-lactam/beta-lactamase inhibitor (BLBLI) combinations, such as cefepime-enmetazobactam and ceftolozane-tazobactam, and also emphasizes on avoiding important drugs like ceftazidime-avibactam for ESBL -producing Enterobacterales.

Authors

Institutions

Publication Details

Journal
Indian Journal of Medical Microbiology
Published
2025-09-17
DOI
https://doi.org/10.1016/j.ijmmb.2025.100974
Primary Topic
Antibiotic Resistance in Bacteria
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Management of infections caused by Extended-spectrum beta-lactamase-producing Enterobacterales in Indian patients

N.K. Bansal, Ram Gopalakrishnan, Pallab Ray, V. Ramasubramanian et al.
Indian Journal of Medical Microbiology
Antibiotic Resistance in Bacteria
article

Management of infections caused by Extended-spectrum beta-lactamase-producing Enterobacterales in Indian patients

N.K. Bansal, Ram Gopalakrishnan, Pallab Ray, V. Ramasubramanian, Kamini Walia, Sonam Vijay, Rajalakshmi Arjun, George M. Varghese, Vasant Nagvekar, Balaji Veeraraghavan, Neha Gupta, Priscilla Rupali, Sanjay Bhattacharya, Camilla Rodrigues
article en

Abstract

This guidance document highlights the importance of early and accurate identification of ESBL -producing Enterobacterales, outlines clinical syndromes that may require empirical antibiotic coverage for ESBLs, and offers guidance on appropriate de-escalation strategies. Additionally, it emphasizes on the optimal use of use of newer beta-lactam/beta-lactamase inhibitor (BLBLI) combinations, such as cefepime-enmetazobactam and ceftolozane-tazobactam, and also emphasizes on avoiding important drugs like ceftazidime-avibactam for ESBL -producing Enterobacterales.

Indian Journal of Medical MicrobiologyVol. 58
Apollo Hospitals (IN), Christian Medical College, Vellore (IN), Sir H.N. Reliance Foundation Hospital and Research Centre (IN), P. D. Hinduja Hospital and Medical Research Centre (IN), Indian Council of Medical Research (IN), Tata Medical Center (IN), Rajiv Gandhi Cancer Institute and Research Centre (IN), Fortis Memorial Research Institute (IN), Kerala Institute of Medical Sciences (IN), Post Graduate Institute of Medical Education and Research (IN)
Openalex Percentile: Top 80%
Antibiotic Resistance in Bacteria
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Management of infections caused by Extended-spectrum beta-lactamase-producing Enterobacterales in Indian patients — N.K. Bansal, Ram Gopalakrishnan, et al. · Indian Journal of Medical Microbiology (2025) | TGRS Research Map | TGRS